Will Weise and the Science That Could Bring Endangered Species Back From the Brink

John Mulder on Making Hidden Metabolic Risk Visible

Diagnoptics Technologies CEO John Mulder explains how advanced glycation end products, or AGEs, can reveal long-term metabolic stress before symptoms appear. His work focuses on making invisible lifestyle-related risk measurable, understandable, and actionable.

Holley Miller on Why Healthcare Launches Fail

Holley Proctor Miller, Founder and President of Grey Matter Marketing, explains why so many healthcare and life sciences launches fail despite strong technology and real clinical value. Drawing on decades of experience in medical marketing, robotics, devices, and patient adoption strategy, she breaks down why companies need to define the problem before selling the solution. The conversation explores healthcare innovation, product launches, patient behavior, robotics, data, and the emotional reasons people change.

Dustin Carlson on the AI Insurance Gap Every Business Needs to Understand

Dustin Carlson, President of SRA 831(b) Admin, explains how AI is creating new liabilities that many traditional insurance policies may not cover. As businesses adopt generative AI for operations, marketing, customer service, and internal workflows, they may also be taking on risks tied to hallucinations, intellectual property, data exposure, and denied claims. The conversation explores AI exclusions, self-insurance, 831(b) plans, cyber risk, and why business owners need to review their coverage before a problem happens.

Katie Newman on Why Rural Hospitals Need More Than Survival Plans

Katie Newman, CEO of High Point Healthcare Real Estate, joins Innovation Saves Lives to discuss how real estate strategy and creative capital can help rural hospitals stay open, modernize facilities, and keep care local. She explains why inaction is often the greatest risk facing underserved healthcare systems and how layered financing models can create new options for communities that traditional lenders overlook.

Joseph Zapolsky III on Building Erchonia's Global Legacy in Non-Invasive Laser Therapy

Joseph Zapolsky III shares the story behind Erchonia's rise from a garage startup to a global leader in low-level laser therapy. The conversation explores how non-invasive laser treatments are being used for pain management, body contouring, and emerging applications in dentistry and veterinary medicine. Zapolsky also discusses the company's 30-year journey, its commitment to clinical research, and how new technologies are shaping the future of patient care.